Thursday, July 30, 2020
Biocon Biologics valued at $3.5 billion after Tata Capital's $30 million financing
Through investments in R&D and high-quality manufacturing infrastructure, we are confident of achieving our aspiration of serving 5 million patients through our biosimilars portfolio, CEO Hamachar said https://ift.tt/33dByn4 https://ift.tt/eA8V8J
Subscribe to:
Post Comments (Atom)
How internet censorship tech maker Sandvine, a vendor to repressive regimes like Egypt, nearly collapsed before US restrictions forced new ownership and a pivot (Ryan Gallagher/Bloomberg)
Ryan Gallagher / Bloomberg : How internet censorship tech maker Sandvine, a vendor to repressive regimes like Egypt, nearly collapsed bef...
-
Amrith Ramkumar / Wall Street Journal : An interview with White House OSTP Director Michael Kratsios, a Peter Thiel protégé confirmed by ...
-
The first project we remember working on together was drawing scenes from the picture books that our mom brought with her when she immigrate...
No comments:
Post a Comment